Benjamin Lockshin, MD, FAAD: Management of Psoriasis With Bimekizumab
Benjamin Lockshin, MD, FAAD, the director of the Clinical Trials Center at U.S. Dermatology Partners, discusses using bimekizumab (Bimzelx) for the treatment of moderate-to-severe psoriasis
